Articles tagged with Kidney
A high protein diet may harm polar bears, with captive bears showing signs of kidney disease and shorter lifespans. Researchers propose adopting a diet with a fat-protein ratio similar to that found in the wild to improve bear health and longevity.
A recent study published in Transplantation Direct highlights the increased risk of death from cancer and infection for kidney transplant patients. Focusing on lifestyle changes such as weight loss, exercise, and diabetes management can improve long-term outcomes for these patients.
A recent study found that the number of stage 3 AKI kidneys transplanted in the US has increased significantly over the last decade, yet 44% are still discarded. This highlights the need for further efforts to optimize the use of these organs and reduce waste.
Research from the University of Virginia Health System found that long-term use of ACE inhibitors and angiotensin receptor blockers can lead to hardened kidney vessels. The drugs, commonly prescribed for high blood pressure and heart failure, were associated with damage in both lab mice and humans.
A new targeted therapy inhibits specific immune cells associated with lupus nephritis, improving kidney inflammation in animal models. Elevated levels of ALCAM molecules suggest a potential new path toward personalized medicine.
A case series found that a fourth dose of an mRNA-based vaccine increases antispike IgG titers in kidney transplant recipients with weak serologic response after three doses. The researchers noted no safety concerns with the additional dose and suggested its use for such patients.
A new study finds that climate change will lead to an increase in kidney stone cases, even with mitigation efforts. Researchers predict a cost of $57-99 million to the US healthcare system over seven decades, with a steeper impact if no action is taken.
Researchers at MUSC identified a potent antifibrotic peptide that reverses scarring in human and mouse tissues by activating an antifibrotic pathway. The E4 peptide has the potential to treat various diseases, including heart disease, lung fibrosis, liver cirrhosis, and chronic kidney disease.
Researchers developed a new SERS-based multiplexing technique to detect kidney injury biomarkers SLPI and IL-18, achieving high sensitivity and reliability. The approach shows promise for objectively assessing donor kidney quality, potentially reducing discard rates and recipient complications in clinical practice.
Researchers have developed a highly sensitive immuno-CRISPR assay to detect acute kidney rejection in urine, potentially allowing for early diagnosis without invasive biopsy. The test uses CRISPR/Cas12a gene editing technology to identify biomarkers of rejection, such as CXCL9, with improved sensitivity compared to existing methods.
The THINKER-NEXT trial will transplant 200 kidneys from HCV-positive donors into new patients to assess long-term outcomes and risks. The study aims to increase adoption of this practice nationwide and provide hope for those waiting on the kidney transplant list.
A new study reveals that in many countries, there are significant gaps in care related to the importance of nutrition for maintaining kidney health. Nutritional interventions can slow kidney function decline and reduce symptoms.
A clinical trial will harness synthetic chimeric antigen receptor (CAR) T cells to deplete immune B cells and plasma cells producing donor-specific antibodies, aiming to achieve a compatible kidney match for patients with pre-existing antibodies. The NIH-funded study, led by Penn Medicine, intends to begin enrolling patients in 2022.
A recent study published in CJASN found that patients who undergo retransplantation after a failed first kidney transplant have a longer average survival time compared to those on dialysis. The study analyzed data from 2,346 adults and showed that retransplantation resulted in an additional 5.8 months of life expectancy.
Researchers found scarring in COVID-19 patients' kidneys, which may lead to long-term kidney outcomes. The virus directly causes cell damage, independent of the immune system, according to a new study published in Cell Stem Cell.
New research reveals that COVID-19 vaccinated kidney transplant recipients have impaired antibody responses against emerging SARS-CoV-2 variants, including B.1.351 and B.1.617.2. The study found that these patients require additional vaccinations to maintain high levels of neutralizing antibodies.
Despite receiving three vaccinations, kidney transplant patients have inadequate cellular and humoral protection against SARS-CoV-2, with around 90% showing little to no protection. Researchers are now investigating the efficacy and safety of a human antibody cocktail in these patients.
Researchers have identified a gene that helps the kidney resist damage, which has major implications for Indigenous people with high rates of kidney disease. The discovery reveals that a mutation in the VANGL1 gene can cause the development of kidney disease and allows the immune system to attack the kidney.
A new study presented at Euroanaesthesia found that critically ill COVID-19 patients with acute kidney injury are more likely to die in the ICU than those with pre-existing chronic kidney disease. The study also showed that dialysis treatment has little impact on survival rates for these patients.
New research suggests that cannabis use can lead to harmful drug-drug interactions by interfering with two families of enzymes that metabolize a wide range of drugs. This could result in unintended side effects such as toxicity or accidental overdose, particularly for older individuals using medications.
Researchers at NYU Langone Health have successfully performed their second xenotransplantation procedure using a genetically engineered pig kidney. The procedure, part of an ongoing study, demonstrates continued promise for these genetically engineered organs as a renewable source of life-saving gifts.
Alphataxin, a small-molecule drug, has been shown to significantly suppress tumor growth in mouse models of kidney cancer, including those with lung metastasis. The treatment also increased the formation of CD4+ T cells, which is essential for the immune system's ability to kill tumor cells.
A patient-centered rehabilitation program reduced hospital rehospitalization and mortality in high-risk patients with acute kidney injury. The study found that participation in the program significantly lowered rates of rehospitalization and mortality, with a 15% readmission rate compared to 34% for non-participants.
A new method measures glomerular filtration rate using D-serine clearance, showing strong correlation with GFR and lower bias than creatinine clearance. This could improve clinical practice and reduce dialysis patients.
A study surveyed AKI survivors to reveal its physical, social, and emotional effects. The results show the need for interventions to improve health-related quality-of-life for AKI patients.
A new study led by Prof. Motoko Yanagita found that the suppression of two molecules, CD153 and CD30, expressed on immune cells mitigates the progression of kidney disease in aged kidneys. This discovery identifies a promising therapeutic target for kidney treatment in the elderly.
A scoping review highlights the evolution of video-based telemedicine for chronic kidney disease management, showing improved clinical outcomes and patient satisfaction. However, access to broadband internet and technology literacy remain significant barriers.
A recent study compared immune responses in patients with and without kidney failure following different COVID-19 vaccines. The findings suggest that higher doses of the mRNA-1273 vaccine may improve SARS-CoV-2 vaccine effectiveness in hemodialysis patients.
A new study published in Annals of Medicine recommends that athletes returning to training after long COVID undergo a series of tests and receive regular advice from medical specialists. The researchers defined long COVID as symptoms lasting more than four weeks, and warned of the risk of organ damage and mental health issues.
Researchers found that cerebral palsy patients with low muscle mass often have inaccurately calculated kidney function, leading to missed diagnoses of advanced kidney disease. This association increases the risk of cardiovascular disease and mortality in this population.
A new risk score developed by Mount Sinai researchers can help predict possible contrast-associated acute kidney injury among patients undergoing PCI. The 'Mehran-2 CA-AKI Risk Score' enhances management of high-risk patients before, during, and after the procedure.
A recent study discovered high levels of mercury exposure in human bones from Copper Age Iberia, dating back 5000 years. Cinnabar powder used for pigments and rituals led to severe health effects, including intoxication.
A new study led by Professor Motoko Yanagita has found that advanced tertiary lymphoid tissues in kidney transplant patients are associated with progressive graft dysfunction. The presence of these tissues, which arise in chronic inflammatory conditions, can indicate a higher risk of renal failure within five years.
A study published in the New England Journal of Medicine found that chlorthalidone significantly lowered blood pressure by 11mmHg in patients with stage 4 chronic kidney disease. The results also showed a 50% reduction in albuminuria, suggesting potential benefits for reducing kidney failure progression and hospitalizations.
An international research team discovered that intestinal bacteria can distribute their metabolic products throughout the body via the bloodstream using membrane vesicles. The study found that these vesicles can overcome the blood-brain barrier and enter brain cells, suggesting a new method for delivering drugs or vaccines.
The University of Maryland School of Medicine has been awarded a $6.5M grant to develop a treatment for alcoholic liver disease-associated kidney dysfunction. The Institute of Human Virology and MitoPower will conduct clinical trials to test the safety and efficacy of MP-04, a lead compound in treating HRS.
Children in UK and Ireland diagnosed with larger kidney cancers, leading to late diagnosis and potential poorer outcomes. A call for frontline healthcare workers to be trained in paediatric medicine has been made to improve early detection.
Researchers created novel frog models to replicate polycystic kidney disease, allowing for real-time observation of disease processes. AI analysis enabled rapid assessment of disease in the tiny animals.
A new study examines why people object to bodily markets, revealing that both liberals and conservatives consider these markets morally wrong due to different reasons. Liberals believe commercialization can be exploitative, while conservatives view it as violating the sanctity of the human body.
New research identifies coffee metabolites that may affect kidney disease risk, with some associated with higher risks of chronic kidney disease. The study found 3 metabolites linked to increased CKD risk: glycochenodeoxycholate, O-methylcatechol sulfate, and 3-methyl catechol sulfate.
Researchers discovered that spiny mice can regenerate severely damaged kidneys without scarring, a process triggered by unique transcriptional programs in their genome. This finding offers new hope for treatments of end-stage kidney disease and fibrotic diseases.
A new study improves AI diagnoses by penalizing algorithms for false negatives, which can be more urgent than accuracy. Researchers achieved significant improvements in precision and recall for chronic kidney disease and other conditions using cost sensitivity techniques.
Researchers found that certain urinary biomarkers, including neutrophil gelatinase-associated lipocalin and kidney injury molecule-1, were associated with increased risk of severe acute kidney injury or death in patients hospitalized with COVID-19. These biomarkers may help identify patients at high risk for adverse kidney outcomes.
A new four-year study identifies appropriate ethical and policy guidance for translational xenotransplantation kidney clinical trials. The research team will develop recommendations and decision aids for transplant candidates, clinicians, and institutional review boards reviewing xenotransplantation protocols.
A team led by NYU Langone's Robert Montgomery successfully transplanted a genetically engineered pig kidney into a human body, marking a major step forward in xenotransplantation. The procedure, performed on September 25, 2021, used a GalSafeTM pig with the alpha-gal biomolecule removed to avoid rejection.
A targeted drug, cabozantinib, has shown activity against brain metastases from kidney cancer, achieving a 50% response rate. The drug's ability to reach the brain through the blood-brain barrier offers a promising systemic option for patients with poor life expectancy and intervention tolerability.
A new study found that racial and ethnic disparities in pediatric kidney transplantation decreased significantly after the implementation of the Kidney Allocation System in 2014. The study showed no racial disparities in waitlist time until transplantation before or after the policy change, but disparities remained for time on dialysis...
A new study published in Mayo Clinic Proceedings found that patients with acute kidney injury who receive continuous renal replacement therapy (CRRT) have a high incidence of needing CRRT reinstitution after removal. This contributes to poor 90-day outcomes. Successful CRRT liberation is marginally associated with fewer major adverse k...
A research team from the University of Zurich has identified a common genetic variant in the AQP1 gene that affects treatment efficacy and patient survival on peritoneal dialysis. Patients carrying this variant have a higher risk of death, but researchers found a way to circumvent the problem using colloid osmotic agents.
Researchers found that females rely more heavily on aldosterone to regulate blood pressure, whereas males primarily use angiotensin II. This discovery could lead to targeted treatments for female hypertensive patients, improving treatment outcomes and reducing the risk of heart disease and stroke.
A new protocol combining patient monitoring and monoclonal antibody therapy reduced hospitalizations by half and deaths to zero for eligible patients. The study, conducted at Keck Medicine of USC, shows improved outcomes among liver and kidney transplant recipients with COVID-19.
A new study found that the COVID-19 pandemic led to a 30% decline in patients seeking treatment for kidney failure, with Black patients experiencing significantly worse kidney function. The decline was attributed to changes in healthcare delivery and may reflect delays in treatment due to fear of infection or logistical barriers.
A plasma biomarker panel identified a combination of sTNFR1, sTNFR2, cystatin C, and eGFR that discriminated between patients with worsening or low risk of chronic kidney disease after three years. This combination was particularly effective at identifying those with very low risk of subsequent kidney dysfunction.
A national review of nocardia infection in kidney transplant patients found that those with compromised immune responses are more vulnerable to the opportunistic agent. Nocardiosis can lead to pneumonia and brain abscess, and screening is crucial, especially in combination with pneumonia symptoms.
A survey of US transplant centers found a consensus to remove race-based adjustments from kidney function calculations, but also acknowledged potential harms of dropping the adjustment. The study aims to reduce healthcare disparities and improve patient care.
An analysis of Medicare's Comprehensive ESRD Care Initiative found that factors like leaner operations, organizational experience, and community resources contribute to successful performance. The study aims to inform healthcare providers and policymakers in developing value-based payment models for kidney care.
The National Kidney Foundation has released a research roadmap to accelerate innovations in treatment and increase understanding of kidney disease. The report calls for increased funding in preclinical science, genetics, health equity, and implementation science to tackle the most vexing challenges in kidney disease.
A new patient decision aid developed by Duke-NUS Medical School's experts empowers patients with ESKD to choose care strategies consistent with their values and goals. The tool provides a balanced overview of dialysis, kidney supportive care, and other treatment options.
Researchers at Medical University of Vienna discovered that lithium chloride can reduce peritoneal thickening, fibrosis markers, and αB-crystalline expression in mesothelial cells. This innovative solution aims to preserve the peritoneum for longer, allowing patients to live a normal life or wait for a transplant.
Research provides insights on immune responses of kidney transplant recipients following SARS-CoV-2 infection. The study found that production of IgG antibodies against the virus was delayed in these individuals, but their IgM and IgA responses were similar to those observed in non-transplant individuals.